Biomarin Pharmaceutical Inc (BMRN)

Exchange
NASDAQ
Symbol
BMRN
Sector
Healthcare
Industry
Biotechnology
Description
BioMarin Pharmaceutical Inc. is a prominent biotechnology company headquartered in San Rafael, California, focusing on the development of innovative therapies for rare genetic disorders and other complex medical conditions. Renowned for its pioneering advancements in enzyme replacement therapies, BioMarin boasts a robust portfolio of approved products, including treatments for phenylketonuria (PKU) and other rare diseases. The company is dedicated to leveraging cutting-edge science and technology to address significant unmet medical needs, backed by a strong commitment to research and development. With a solid growth trajectory and a mission to enhance the quality of life for patients worldwide, BioMarin is strategically positioned to lead in the rare disease therapeutic landscape.
Country
USA

Stock price

At close: February 5, 2026

  • Open
    57.69
  • High
    58.29
  • Low
    56.87
  • Close
    57.15
  • Volume
    1,256,880

Financial ratios

Sep 30, 2025